5.40
+0.22
+(4.25%)
At close: January 30 at 4:00:02 PM EST
5.20
-0.20
(-3.70%)
Pre-Market: 5:26:54 AM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-30,671.46
-30,326.13
-56,637.19
-42,555.91
-37,493.46
Investing Cash Flow
-43,351.88
30,000.00
-29,954.53
-7.81
29,023.91
Financing Cash Flow
-1,191.51
-1,270.22
1,220.09
194,496.39
41,902.03
End Cash Position
68,120.03
142,823.02
144,419.36
229,790.99
77,858.31
Interest Paid Supplemental Data
1,769.00
1,702.19
1,338.54
1,337.08
1,387.75
Capital Expenditure
-9.53
--
-16.32
-7.81
--
Issuance of Capital Stock
--
--
--
189,811.61
40,716.54
Free Cash Flow
-30,671.46
-30,326.13
-56,653.50
-42,563.71
-37,493.46
12/31/2020 - 5/2/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ABEO Abeona Therapeutics Inc.
5.47
+0.37%
MIST Milestone Pharmaceuticals Inc.
2.0200
+1.00%
ARDX Ardelyx, Inc.
5.36
-2.19%
KALA KALA BIO, Inc.
9.48
+8.59%
URGN UroGen Pharma Ltd.
11.35
+3.09%
INZY Inozyme Pharma, Inc.
1.4600
+2.82%
FOLD Amicus Therapeutics, Inc.
9.64
+0.52%
SCPH scPharmaceuticals Inc.
3.4500
+4.86%
PLX Protalix BioTherapeutics, Inc.
2.3800
+0.42%
MGTX MeiraGTx Holdings plc
6.43
+3.46%